Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $500,000
- Closes
- Jul 5, 2029 (in 981 days)
Similar opportunities open now
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2028
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 2028
Classification and identifiers
- Solicitation number
- PAR-27-072
- Assistance listing (CFDA)
- 93.395
Amount
$500,000
Who can apply
Small businesses, State government agencies, and Nonprofits can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
About this opportunity
This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science. This NOFO will support clinical trials that test functionality or validate performa...